Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genetic Assessment of the Patients With Metabolic Syndrome (GENMetS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Medical Universtity of Lodz.
Recruitment status was  Active, not recruiting
Information provided by:
Medical Universtity of Lodz Identifier:
First received: December 28, 2010
Last updated: July 20, 2011
Last verified: December 2010

December 28, 2010
July 20, 2011
December 2010
August 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01268696 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Genetic Assessment of the Patients With Metabolic Syndrome
Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:

weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

Eligibility criteria to the study:

  • patients with metabolic syndrome
  • with written consent
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
the blood samples taken into EDTA
Probability Sample
Patients with metabolic syndrome
Metabolic Syndrome
Not Provided
  • control group
    healthy volunteers
  • Metabolic group
    Patients with metabolic syndrome
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Active, not recruiting
January 2015
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with metabolic syndrome according to IDF,AHA and NHLBI 2009

Exclusion Criteria:

  • diabetes type 1
  • cancer
  • not consent
  • steroid therapy
  • alcohol or drug abuse
  • chronic inflammatory disease
  • pregnancy or lactation
  • severe hypothyroidism
  • immunosuppressive treatment
  • operation or severe injury during the last month
18 Years to 80 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Department of Medical Biotechnology, Medical University of Lodz
Medical Universtity of Lodz
Not Provided
Study Chair: Tadeusz Pietrucha, prof. Department of medical biotechnology
Medical Universtity of Lodz
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP